Morning Overview on MSN
A common diabetes drug is showing signs of slowing aging in people
Metformin, a drug prescribed to tens of millions of people with type 2 diabetes, is producing measurable shifts in molecular ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved JANUMET ® XR ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Treatment with the diabetes drug metformin shows a significant, dose-dependent effect in lowering ...
Early metformin treatment in mild-to-moderate COVID may not prevent long-term symptoms but is linked to relatively fewer clinician-diagnosed cases, a study finds.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with poorly controlled type 2 diabetes assigned ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions from a study comparing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results